|
HCPCS 2008 > Q Codes >  2008 HCPCS Q0180
- Dolasetron mesylate, 100 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen
- Added on Wednesday, April 01, 1998
- BETOS Classification: Chemotherapy
- Medicare coverage status: Special coverage instructions apply
 Q0179 Q0181 
|
|
|
